Paxlovid is now approved for treating adults. Results from a pivotal clinical showed that Paxlovid led to an 86% reduction in COVID-19-related hospitalization or death from any cause compared to a placebo.
The post FDA Nod Makes Pfizer’s Paxlovid The First Approved Oral COVID-19 Antiviral Drug appeared first on Above the Law.
“The issue is, what is milk?” The FDA uses the term “milk” to describe cowmilk [FN], but that isn’t a single commercial product from a…
The unexpected death of a loved one can leave you feeling desolate, especially if someone’s negligence caused the death. While you are probably more concerned…
The field of patent law is complex and evolving, constantly addressing the intersection between innovation and intellectual property rights. One critical aspect of patent infringement…
A Georgia physician pleaded guilty today to charges related to the sale of a purported weight loss drug product that contained human chorionic gonadotropin, or…
Pfizer’s Abrysvo is now approved for preventing illness caused by respiratory syncytial virus, or RSV, in adults 60 and older. The regulatory decision comes weeks…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Responses